Pursuant to SEBI Circular dated 31-12-2024 read with BSE circular no 20250102-4 we are submitting herewith our Integrated Filing (Financial) for the Quarter and Year Ended 31-03-2025. ....

Revenue declinedNegative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.9%Reaction day

₹58.00

prior close

₹60.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.2%-2.1% vs market

Pharmaceuticals peers, median of 150sector+1.0%-1.8% vs sector

On the reaction day the stock moved 2.1 pts less than Nifty Microcap 250 and 1.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.2

15m

-0.2

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.9+1.2-2.1+1.0-1.8

Next day

-1.7+0.1-1.8-0.2-1.6

-6.6+0.9-7.5+0.6-7.3

-2.0+0.8-2.8+0.2-2.2

+1.7+1.4+0.3+0.1+1.6

+3.4+2.0+1.4+0.5+2.9

+8.3+2.3+6.0+1.5+6.8

15d

+3.6+5.2-1.5+1.4+2.2

-11.8+1.6-13.3-1.4-10.3

-7.2+7.7-14.9+3.7-11.0

-27.2+4.0-31.2-0.2-27.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Colinz Laboratories submitted its audited standalone financial results for Q4 and full year ended March 2025. Revenue from operations fell to Rs 652.77 lakhs in FY25 from Rs 702.96 lakhs in FY24, a decline of about 7%, while Q4 revenue also dropped to Rs 145.14 lakhs from Rs 162.94 lakhs. Profit after tax was nearly flat at Rs 49.66 lakhs versus Rs 48.67 lakhs, with EPS of Rs 1.97 versus Rs 1.93. However, the company reported a sharp swing in operating cash flow, turning negative at Rs (145.37) lakhs for FY25 compared to a positive Rs 103.47 lakhs last year, driven mainly by a large increase in other current assets. The statutory auditor Vora & Associates issued an unqualified opinion on the results.

Likely market impact

Mixed signals for shareholders — topline shrank and operating cash flow turned sharply negative, though bottom-line profit stayed steady. The negative operating cash flow despite positive accounting profit is a red flag worth monitoring, while the clean audit opinion provides some comfort.